MedPath

Effect of Aggression Management Care Bundle

Not Applicable
Recruiting
Conditions
Aggression
Registration Number
NCT06661824
Lead Sponsor
Abant Izzet Baysal University
Brief Summary

The aim of this sequential randomized controlled experimental design study is to develop an aggression care bundle approach in psychiatric care for patients with psychotic disorders, to use it in a psychiatric clinic, and to evaluate its results. The hypotheses it aims to test are as follows:

1. The aggression management care bundle applied to patients with psychotic disorders in a psychiatric clinic will reduce the risk of developing aggression.

2. The number of aggressive events in the patient group to whom the aggression management care bundle is applied will be less than the control group receiving routine care.

3. The use of restrictive aggression management techniques in the clinic will decrease.

4. The clinical compliance rate of the developed aggression management care bundle will be 95% and above.

Detailed Description

Psychopathology plays an important role in the emergence of aggression. Having a diagnosis of psychotic disorder or schizophrenia is an important psychopathology that leads to aggression. For these reasons, aggression and how to manage it is an ongoing problem in psychiatric clinics. The prevalence of aggressive behavior in psychiatric wards varies between 8-76%. The prevalence of aggression in schizophrenia patients is stated as 33.3%. This aggression can be verbal, directed towards objects/spaces, towards oneself or physical aggression towards others. Healthcare professionals in psychiatric wards are exposed to these aggressive events carried out by patients. It is reported that 25-85% of healthcare professionals working in psychiatric wards are exposed to aggressive events; the prevalence of aggression towards nurses varies between 11.4-97.6%. Over the years, some methods have been developed and used to manage aggression in psychiatric wards. Chemical and mechanical restraint and seclusion methods are still the leading methods used. There is a need for alternative and evidence-based interventions based on therapeutic nursing approaches to manage aggression in psychiatric wards, which can be easily adopted and implemented in the clinic. Therefore, it was aimed to develop and use the "care bundle" approach, which has been shown to improve patient outcomes in the literature, for aggression management in psychiatric wards. Care bundles are care tools that target a specific patient population, consist of 3-5 evidence-based approaches, and improve patient outcomes when used together. In this study, it was planned to develop the aggression management care package in phase 1, and evaluate the clinical use of the aggression management care bundle in phase 2. The aggression management care bundle was developed following the guidelines of The Institute for Healthcare Improvement.

Recruitment & Eligibility

Status
RECRUITING
Sex
Male
Target Recruitment
24
Inclusion Criteria
  • Being between 18-65 years of age,
  • Being able to speak and understand Turkish,
  • Having one of the disorders within the scope of Schizophrenia and psychosis,
  • Being newly admitted to Bolu İzzet Baysal Mental Health and Diseases Hospital during the period the research was conducted,
  • Having scored 1 point or more on the Broset Violence Checklist or 65 points or more on the Buss-Perry Aggression Questionnaire.
Exclusion Criteria
  • Not being able to give written informed consent,
  • Being the first time a patient has been admitted to a psychiatric clinic,
  • Having developmental delay or any other significant organic brain pathology.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Primary Outcome Measures
NameTimeMethod
Change in aggression risk during hospitalizationup to 6 weeks (routine hospitalization period)

The primary outcome 1 measure of the study is change in aggression during hospitalization. Aggression risk will be measured in both groups with scales:

Buss-Perry Aggression Questionnaire (BAQ):29-item scale measuring four aggression sub-dimensions on a 5-point Likert scale. Total score: 29-145. Higher scores indicate higher aggression risk.

Change in aggression risk will be compared between hospitalization and discharge, and between control and experimental groups.

Change in aggressive events during hospitalizationup to 6 weeks (routine hospitalization period)

The primary outcome 2 measure of the study is change in aggression during hospitalization.

Aggressive events will be measured in both groups with this scale:

Overt Aggression Scale:Assesses aggression through professional observation. Two sections: Aggressive Behavior and Attempts. Scores: Total Aggression (max 26) and Aggression Score (max 21). Measures severity and frequency of aggressive behavior.

Change in aggressive events will be compared between hospitalization and discharge, and between control and experimental groups.

Change in aggression risk during 24 hoursup to 6 weeks (routine hospitalization period)

The primary outcome 3 measure of the study is change in aggression during 24 hours. Aggression risk will be measured in both groups with scale:

Broset Violence Checklist (BVC):Estimates 24-hour violence risk in acute psychiatric settings. Six behaviors scored 0 or 1. Total score: 0-6. 0 = low risk, 1-2 = medium risk, \>2 = high risk.

Change in aggression risk in during 24 hours will be compared between hospitalization and discharge, and between control and experimental groups.

Secondary Outcome Measures
NameTimeMethod
care bundle compliance rateup to 6 weeks (routine hospitalization period)

The secondary outcome measure is the bundle compliance rate to evaluate the feasibility of the developed care bundle.The care bundle must be adoptable and applicable by nurses. To evaluate this, the number of times they apply which elements will be recorded with the Bundle Compliance Tracking Chart. Consistency and applicability among nurses will be examined. The implementation of the bundle at 95% and above means compliance.

Bundle Compliance Tracking Chart:It was created by researchers. It will be used to mark each element of the six-component care package to be applied to the intervention group as applied to the patient.Thus, it will be tracked which elements are applicable, which cannot be implemented and why, and how many times the elements are implemented.

Trial Locations

Locations (1)

Bolu Mental Health and Diseases Hospital

🇹🇷

Bolu, Bolu Province, Turkey

© Copyright 2025. All Rights Reserved by MedPath